skip to Main Content

[Etoday] C&R Research conducts global clinical trials for Shaperon atopic dermatitis treatment ‘NuGel’

C&R Research announced on the 18th that it has decided to conduct a global clinical trial with Shaperon and InHandPlus.


An official from C&R Research said, “Based on our experience in conducting more than 1,800 clinical trials and global clinical trials, C&R Research is confident in conducting the atopic dermatitis clinical trial for Shaperon, and the results of applying the AI ​​medication management system to the clinical trial are also positive. “We are looking forward to the results,” he said.


<View original article>





Back To Top